Goals & Impact

Between 1989-1993 and 2014-2018, the five-year relative survival for pancreatic cancer improved from 3.5% to 12%. There is more work to be done.

Goals

The goals of the PURPLE Translational Platform are to:

• Accelerate research and improve outcomes in pancreatic cancer
• Improve data sharing and collaboration across laboratories and cancer centres
• Create a comprehensive information system that is efficient and scalable

Impact

To improve outcomes in pancreatic cancer, it is crucial that greater participation in and access to new drug treatment and clinical trials is encouraged.  The PURPLE Translational Platform, with its innovative, collaborative, systems biology-based approach and capability to analyse ‘real world’ data, is providing valuable insights to guide improvements in clinical practice and optimise treatment selection.